A continuous postoperative sivelestat infusion reduced ARDS rates versus placebo after cardiovascular surgery (16.8% vs 31.2%; P < .001). Ninety-day all-cause mortality was lower with sivelestat ...
Severe COVID-19 raises lung cancer risk by 24%, study of 76 million Americans finds In A Nutshell People hospitalized with severe COVID-19 had roughly a 24 percent higher risk of developing lung ...